In this video, experts review sulfonylureas’ current role in type 2 diabetes, comparing agents’ safety/efficacy, hypoglycemia risk, and pragmatic use in resource-limited settings.
Prof. Antonio Ceriello – Head of Diabetes Department – IRCCS Multimedica, Milan, Italia
Dr. Mohamed Hassanein – Endocrinology and Diabetes – Dubai Hospital, Dubai, UAE
Dr. Sanjay Agarwal – Head of Diabetes Department – Sahyadri Hospital, Pune, India
Watch the full video to learn more!
Content exclusive for connected users. Please sign in or register to access more.
Already have an account?
Sign inNew here?
Create account
